Omega Therapeutics, Inc.·4

Jan 11, 4:14 PM ET

Young Richard A 4

4 · Omega Therapeutics, Inc. · Filed Jan 11, 2023

Insider Transaction Report

Form 4
Period: 2023-01-10
Young Richard A
Director10% Owner
Transactions
  • Sale

    Common Stock

    2023-01-10$8.00/sh20,000$160,000764,118 total
Footnotes (1)
  • [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION